When a Sponsor chooses to engage with a contract research organization (CRO), the Sponsor team expects quality and performance in return for their investment. CROs are in business to conduct trials - and offload the work from the Sponsor’s side. So why are so many trials fraught with early hiccups? The
Kunal Sampat joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss the changing landscape of clinical trial operations. An experienced Clinical Operations Director, Kunal shares his key learnings from 2020 and elaborates on some of the successes and challenges he’s seen this year. Industry stakeholders
Today, ArcheMedX, a leader in behavior-based learning and operational insights for life sciences and healthcare organizations, announced the results of its new survey, “COVID-19's Impact on Virtual Tech in Clinical Trials.” The findings reveal brand-new insights into how clinical trial leaders in pharmaceuticals, biotech, and clinical research organizations are accelerating
Charlottesville, VA -- July 14, 2020
ArcheMedX leadership is pleased to announce the promotion of Kelly Ritch to EVP of Product and Clinical Research Solutions. Ritch joined in 2019 to support the increasing demand for Ready, the company’s clinical trials platform, with sponsors and CROs.
“Kelly has already made an indelible impact
Until the recent changes forced upon our industry by COVID-19, clinical research has been anything but digital: instead, relying heavily on in-person interaction, monitoring, and data collection.
Many trials have been forced to halt, or change standard operating procedures (SOPs) in order to restart. The adoption of digital solutions has accelerated.
While industry media are reporting that some clinical trials that had been paused are restarting, much of our industry remains stalled due to COVID-19. If you’re among those still in limbo, you may be struggling with how to prioritize your time right now to prepare for restarting. We’ve put together